
结论很明确:这个市场不值得进入,已经进入明显的价格战区,而且新品牌成功率只有7.27%,属于高风险市场。 现有数据同时显示新品牌数量已达到21个、老品牌35个,竞争已经不是“能不能做”,而是“谁愿意用更重的投入去硬扛亏损和流量成本”。
从证据看,市场正在往更差的方向走:近年新产品利润表现几乎被压扁,全年新发布产品里只有7.69%能盈利;按新品牌口径,盈利率也只有10.34%,仍然偏低。利润分布里,新产品利润区间集中在低位,-11.57%到9.99%,说明大多数新品都在亏损或贴近盈亏线。节奏上,2026年大量新品牌涌入,但大部分都是失败样本,尤其4月到6月几乎全是未盈利新品牌,说明市场不是增长期,而是拥挤期。大品牌里,Garnier、Caudalie、WELEDA、medicube 这些品牌里只有少数新品跑通;真正的样板是 medicube 的 B0FPQGLYK9,售价£16.59,月销6000,月营收£99,540,月利润£14,035.14,但它的前期投入高达£144,915.75,广告就要£32,403.16,说明这不是普通商家能轻松复制的打法。反面例子也很清楚,Beauty of Joseon 的老款 B09JVNZVH3 月销30000,但利润率只有9.48%,新款 B0H5JV4MQR 直接失败,说明连强品牌都被利润压住了。 一句话:这是典型的高压价格战市场,不适合小商家,也不适合普通大品牌贸然进入。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
不建议进入这个市场。 你的预算50万人民币够覆盖单个新品前期启动,但市场已经明显偏向价格战,且新品牌成功率太低;对小商家尤其不友好,对大品牌也不是好市场。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经明显偏向价格战和过度拥挤。 新品牌新上架成功率只有7.27%,低于10%的高风险线;市场可识别盈利产品占比也只有13.22%,而且新产品利润率高密度区间已经被压到很窄,说明大多数新品都在低利润甚至亏损边缘徘徊。
这个市场不值得进入:已经明显拥挤,而且正在走向低利润价格战。 新品牌想靠常规打法赚钱几乎不现实;少数能赚钱的新品,基本都带着强品牌力、强差异化,或明显更高的投入门槛。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
![]() | B0DR9WDR2G | BYOMA | 2025-02-02 | Yes | £11.99 | 5000pcs | £59950.0 | 16.69% | £10005.66 |
![]() | B075NJZJ7X | Heliocare | 2017-09-15 | Yes | £21.87 | 1000pcs | £21870.0 | 18.63% | £4074.39 |
![]() | B01I8TB6IE | Shade All-Natural Sunscreen | 2014-06-18 | Yes | £19.81 | 1000pcs | £19810.0 | 16.87% | £3341.95 |
![]() | B098346QV1 | ANUA | 2025-07-03 | Yes | £16.45 | 1000pcs | £16450.0 | 13.89% | £2284.91 |
![]() | B0DR9Y1MP7 | BYOMA | 2025-02-02 | Yes | £11.9 | 1000pcs | £11900.0 | 16.1% | £1915.9 |
![]() | B0GPWSQN85 | Caudalie | 2026-02-24 | Yes | £15.57 | 1000pcs | £15570.0 | 11.86% | £1846.61 |
![]() | B0F8QTRPNW | Dr.Althea | 2025-06-14 | Yes | £17.94 | 300pcs | £5382.0 | 20.41% | £1098.47 |
![]() | B0B5273DN1 | Altruist | 2022-06-24 | Yes | £11.12 | 400pcs | £4448.0 | 14.76% | £656.53 |
![]() | B0C1S6X6BJ | Suntribe | 2018-04-28 | Yes | £25.68 | 100pcs | £2568.0 | 20.2% | £518.74 |
![]() | B0DNJZX3LG | SAFE SEA | 2025-03-03 | Yes | £20.5 | 100pcs | £2050.0 | 17.08% | £350.14 |
![]() | B0GLYPXYTZ | WELEDA | 2026-02-23 | Yes | £18.94 | 100pcs | £1894.0 | 16.47% | £311.95 |
![]() | B08ZT1G574 | LIFEJACKET | 2021-03-10 | Yes | £17.99 | 100pcs | £1799.0 | 14.82% | £266.62 |
![]() | B0F8QTVMFZ | Dr.Althea | 2025-06-14 | Yes | £17.43 | 100pcs | £1743.0 | 14.72% | £256.57 |
![]() | B0G58VTRMS | Garnier | 2026-01-01 | Yes | £9.31 | 100pcs | £931.0 | 11.8% | £109.86 |
![]() | B081S2D3BL | RoKai | 2023-11-08 | Yes | £15.85 | 50pcs | £792.5 | 11.8% | £93.52 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
![]() | B0GPWSQN85 | Caudalie | 2026-02-24 | Yes | £15.57 | 1000pcs | £15570.0 | 11.86% | £1846.61 |
![]() | B0GLYPXYTZ | WELEDA | 2026-02-23 | Yes | £18.94 | 100pcs | £1894.0 | 16.47% | £311.95 |
![]() | B0G58VTRMS | Garnier | 2026-01-01 | Yes | £9.31 | 100pcs | £931.0 | 11.8% | £109.86 |
这个市场不值得进入,已经进入明显的价格战区,而且对新品牌几乎是高风险。 新品成功率只有7.69%,新品牌新品成功率也只有11.11%,远低于你要求的安全线;同时多数新品利润率集中在10%上下,很多低于10%,这说明不是“还能做”,而是“很容易做成亏钱生意”。
从数据看,市场里新品牌和老品牌都在被挤压,但老品牌优势更明显。老品牌新品里只有1个盈利样本,成功率仅4.17%;新品牌里也只有3个盈利样本,盈利品牌只有WELEDA、Caudalie、medicube。更关键的是,非盈利样本里旧品牌占比很重,像 ST. MORIZ、Piz Buin、Garnier、Nivea Sun、Lumiter、UFkeanlo 都反复出现在亏损名单里,说明这个类目不是单纯“没品牌能做”,而是连大品牌都在被价格和同质化拖进低利润泥潭。当前市场里所有可识别盈利产品的总盈利率也只有13.22%,新品盈利率更低到7.27%,这就是典型的高压竞争市场。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,已经进入过度拥挤和价格战风险区。 近一年新品牌释放的新品里,只有 7.27% 能被判定为盈利;按最近这批可确认样本看,盈利新品仅 4/52 = 7.69%,非盈利占 92.31%,明显低于你设定的可接受线。市场节奏也在恶化:2025年只有少量样本,到了2026年新品牌密集涌入,单年出现了 41 个新品牌新品失败,这已经是典型的拥挤期,不是机会期。
大品牌角度,只有像 medicube、Garnier、Caudalie、WELEDA 这种已经能打出结果的品牌才有资格继续卷;其中 B0FPQGLYK9(medicube) 是最强样板,售价 £16.59、利润率 14.1%、月销 6000、月营收 £99,540、月利润 £14,035.14,但它的前期投入高达 $144,915.75,光广告就 $32,403.16,说明这不是低预算打法,而是重投放+强品牌+白帽打法。相反,旧品牌 Beauty of Joseon 的新款 B0H5JV4MQR 直接失败;它的老款 B09JVNZVH3 虽然月销 30000、营收 £38,550,000,但利润率只有 9.48%,已经低于盈利线,说明这个市场连大牌都在被利润压扁。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| 2026 | 1 | 1 | 2 | 4 | 0 | 0 | 0 | 40 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 |
| 2026/2 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 2 |
| 2026/3 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 7 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |